Respiratory System Infections: Microbiology, Pathogenesis, and Clinical Features

Study Guide - Smart Notes

Tailored notes based on your materials, expanded with key definitions, examples, and context.

Respiratory System Infections

Overview of the Respiratory System

The human respiratory system is divided into upper and lower tracts, each with distinct anatomical features and functions. The respiratory tract is the most common portal of entry for microbes, making it a frequent site of infection. Understanding the anatomy and defense mechanisms of the respiratory system is essential for recognizing how infections develop and spread.

Upper respiratory tract: Includes the paranasal sinuses, nasal cavity, pharynx, and epiglottis. Functions to warm, humidify, and filter air.
Lower respiratory tract: Comprises the larynx, trachea, bronchi, bronchioles, and alveoli. Responsible for directing air to the lungs and facilitating gas exchange.

Anatomy of the human respiratory system, showing upper and lower respiratory tract divisions

Factors Limiting Respiratory Infections

Mucociliary escalator: Ciliated mucous membranes trap and sweep debris and microbes toward the mouth, preventing entry into the lungs.
Alveolar macrophages: Immune cells in the alveoli clear out debris and pathogens not trapped by the mucociliary escalator.

Mucociliary escalator in the lower respiratory tract

Common Terminology in Respiratory Infections

Sinusitis: Inflammation of the sinus membranes, often due to infection or allergens, leading to blocked drainage and mucus accumulation.
Pharyngitis: Inflammation of the pharynx (throat), caused by bacteria, viruses, or allergens.
Epiglottitis: Inflammation and swelling of the epiglottis, which can block the airway and is a medical emergency.
Laryngitis: Inflammation of the larynx, often causing temporary voice loss.
Tracheitis: Inflammation of the trachea.
Bronchitis: Inflammation of the bronchi and/or bronchioles.
Croup: Combined inflammation of the larynx, trachea, bronchi, and bronchioles, usually viral in origin.
Pneumonia: Inflammation of the lung tissue, which can be life-threatening.
Dyspnea: Shortness of breath.
Stridor: Wheezing or loud breathing due to a blocked or narrowed airway.

Healthy sinuses vs. sinusitis, showing mucus accumulation and inflammation

Respiratory Tract Microbiome

Normal Flora and Its Role

The respiratory tract is colonized by a diverse microbiome, which varies between individuals and health states. The normal flora competes with pathogens and can secrete antimicrobial peptides, providing a protective effect.

Upper respiratory tract: Dominated by Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, and Fusobacteria.
Lungs: Once thought sterile, now known to harbor microbiota similar to the mouth.

Distribution of respiratory tract microbiota

Viral Infections of the Respiratory System

Common Cold

The common cold is the most frequent acute respiratory infection, caused by over 200 genetically distinct viruses. It is highly infectious and usually self-limiting, but can lead to secondary bacterial infections.

Main causative agents: Rhinoviruses and coronaviruses (60–80% of cases), parainfluenza viruses, adenoviruses, and nonpolio enteroviruses.
Transmission: Personal contact, respiratory droplets, and fomites.
Symptoms: Sore throat, runny nose, cough, sneezing, fatigue, body aches, low-grade fever (especially in children), and thickened mucus in later stages.

Respiratory Syncytial Virus (RSV)

RSV is a leading cause of acute lower respiratory tract infection in children under 5 and can be severe in infants and the elderly.

Etiological agent: Enveloped RNA virus, Paramyxoviridae family.
Transmission: Respiratory droplets and fomites.
Symptoms: Coughing, sneezing, fever, and wheezing.
Prevention: Sanitary practices, hand washing, and antibody injections for high-risk groups.

RSV virions under electron microscopy

Human Parainfluenza Virus (HPIV)

Etiological agent: Single-stranded RNA viruses, Paramyxoviridae family.
Symptoms: Cold-like in adults; croup, bronchitis, and pneumonia in children.
Transmission: Respiratory droplets and fomites.

Adenovirus Infections

Etiological agent: Nonenveloped DNA viruses, >50 types infect humans.
Symptoms: Sore throat, cold-like symptoms, conjunctivitis, gastroenteritis, and cystitis.
Prevention: Vaccine for types 4 and 7 (military personnel), sanitary practices.

Adenovirus virions under electron microscopy

Influenza

Influenza viruses cause seasonal epidemics and occasional pandemics. There are three main types: A, B, and C, with type A being the most significant for human disease.

Virulence factors: Hemagglutinin (HA) and neuraminidase (NA) glycoprotein spikes.
Antigenic drift: Minor mutations in HA and NA, leading to seasonal outbreaks.
Antigenic shift: Major genetic changes, potentially causing pandemics.
Prevention: Annual vaccination (inactivated, recombinant, or live attenuated vaccines).

Influenza virion under electron microscopy

Coronaviruses and COVID-19

Coronaviruses are a large family of enveloped RNA viruses. SARS-CoV-2, the cause of COVID-19, emerged in 2019 and led to a global pandemic.

Transmission: Respiratory droplets and aerosols.
Symptoms: Fever, cough, shortness of breath, fatigue, loss of smell, and more.
Complications: Acute respiratory distress syndrome (ARDS), cytokine storm, multi-organ failure.
Diagnosis: RT-PCR for viral RNA, rapid antigen tests.
Prevention: Vaccination, sanitary practices.

SARS-CoV-2 virions under electron microscopy

Hantavirus Pulmonary Syndrome (HPS)

Etiological agent: Hantavirus (genus Hantavirus), >40 known viruses.
Transmission: Inhalation of dust containing rodent urine or feces.
Symptoms: Flu-like symptoms, can progress to pulmonary edema and has a high mortality rate (30–40%).

Hantavirus transmission cycle involving rodents and humans

Bacterial Infections of the Respiratory System

Otitis Media

Otitis media is a common bacterial complication of colds, especially in children due to anatomical differences in the eustachian tube.

Etiological agents: Streptococcus pneumoniae, Moraxella catarrhalis, nontypable Haemophilus influenzae.
Symptoms: Earache, redness, pus or blood leakage, fever.
Prevention: Pneumococcal conjugate vaccine, ear tubes for recurrent infections.

Anatomy of the ear in children and adults, showing tube insertion for otitis media

Streptococcus pyogenes and Strep Throat

Etiological agent: Group A Streptococcus (GAS), S. pyogenes.
Symptoms: Sore throat, swollen lymph nodes, fever, exudate in throat/tonsils.
Complications: Scarlet fever, rheumatic fever, otitis, sinusitis, pneumonia.
Diagnosis: Rapid strep test, culture.
Treatment: Penicillin-based or macrolide antibiotics.

Clinical presentation of strep throat with exudate

Scarlet Fever

Etiological agent: Lysogenized S. pyogenes producing erythrogenic toxin.
Symptoms: Red sandpaper-like rash, strawberry tongue, rash progression from face/neck down the body.

Scarlet fever rash and strawberry tongue

Autoimmune Complications of S. pyogenes

Rheumatic fever: Autoimmune response triggered by cross-reactive antibodies to M protein, affecting joints, heart, and nervous system.

Diagram of cross-reactive antibodies in rheumatic fever

Diphtheria

Etiological agent: Corynebacterium diphtheriae, Gram-positive rod.
Symptoms: Sore throat, low-grade fever, pseudomembrane in airway, "bull neck" appearance.
Complications: A-B exotoxin can cause systemic effects and death if untreated.
Prevention: DTaP vaccine.

Clinical presentation of diphtheria with bull neck and pseudomembrane

Pertussis (Whooping Cough)

Etiological agent: Bordetella pertussis, Gram-negative bacterium.
Stages: Catarrhal (cold-like), paroxysmal (severe coughing), convalescent (recovery).
Complications: Vomiting, rib fractures, neurological symptoms in children.
Prevention: DTaP/Tdap vaccine, booster recommended for adults and high-risk groups.

Infographic of pertussis symptoms and progression Graph of pertussis incidence by age group over time

Tuberculosis (TB)

Pathogenesis and Clinical Features

Etiological agent: Mycobacterium tuberculosis, acid-fast rod.
Transmission: Respiratory droplets from active TB patients.
Progression: Most develop latent infection; some progress to active TB with cough, fever, night sweats, weight loss.
Diagnosis: Mantoux tuberculin skin test, IGRA, molecular diagnostics, chest X-ray, sputum microscopy.
Treatment: Combination antibiotic therapy; MDR and XDR strains require longer, more complex regimens.
Prevention: BCG vaccine in high-risk areas.

Pathogenesis of tuberculosis: initial, latent, and active infection Administering the Mantoux tuberculin skin test Interpreting Mantoux test results by induration size Acid-fast stained Mycobacterium tuberculosis cells

Pneumonia

Classification and Clinical Features

Pneumonia is an inflammation of the lower respiratory tract, caused by a variety of microbes. It is classified as typical or atypical based on clinical presentation and causative agents.

Clinical Feature	Typical Pneumonia	Atypical Pneumonia
General Presentation	High fever, sudden onset, productive cough, chest pain	Lower fever, nonproductive cough, subtle onset, muscle aches
Physical Exam	Respiratory distress, consolidation, crackles	Limited distress, minimal consolidation
Chest X-ray	Fluid accumulation, opaque areas	Patchy/diffuse pattern, minimal fluid
Sputum Culture	Often positive for bacteria	Often negative
Prevalence	4 out of 5 cases	1 out of 5 cases

Pneumococcal Pneumonia

Etiological agent: Streptococcus pneumoniae, Gram-positive encapsulated diplococcus.
Prevention: PCV-13 and PPSV-23 vaccines.
Complications: Otitis media, bacteremia, meningitis.

S. pneumoniae under electron microscopy

Haemophilus influenzae (Hib) Pneumonia

Etiological agent: Haemophilus influenzae, Gram-negative bacteria.
Prevention: Hib conjugate vaccine.

Atypical Bacterial Pneumonia

Common causes: Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella pneumophila, Chlamydophila psittaci, Coxiella burnetii, Francisella tularensis.
Transmission: Respiratory droplets, aerosols, zoonotic sources.

Mycoplasma pneumoniae under electron microscopy Legionella pneumophila under electron microscopy Francisella tularensis under electron microscopy

Fungal Respiratory System Infections

General Features

Fungal infections (mycoses) of the respiratory tract are rare but increasing due to environmental changes and more immune-compromised individuals. Endemic fungi are geographically restricted, while ubiquitous fungi are found worldwide.

Blastomycosis (Chicago Disease)

Etiological agent: Blastomyces dermatitidis, dimorphic fungus.
Transmission: Inhalation of conidia spores from disturbed soil.
Symptoms: Flu-like, pneumonia-like; can disseminate in immune-compromised patients.
Treatment: Antifungal drugs (amphotericin B, fluconazole, itraconazole, ketoconazole).

Blastomyces transmission and infection cycle Blastomyces dermatitidis under microscopy

Coccidioidomycosis (Valley Fever)

Etiological agent: Coccidioides immitis, C. posadasii.
Transmission: Inhalation of arthroconidia spores from soil.
Symptoms: Fever, cough, joint pain, rash; can disseminate in severe cases.
Treatment: Antifungal drugs for severe cases.

Histoplasmosis

Etiological agent: Histoplasma capsulatum, dimorphic fungus.
Transmission: Inhalation of spores from soil enriched with bat or bird droppings.
Symptoms: Atypical pneumonia-like; most cases asymptomatic.
Treatment: Itraconazole for symptomatic cases.

Aspergillosis

Etiological agent: Aspergillus species, especially A. fumigatus.
Transmission: Inhalation of spores; mainly affects immune-compromised patients.
Symptoms: Fever, cough, hemoptysis, difficulty breathing.
Treatment: Voriconazole, amphotericin B, other antifungals.

Mucormycosis

Etiological agent: Rhizopus arrhizus.
Transmission: Inhalation of spores from rotting wood or soil.
Symptoms: Fever, chest pain, cough, shortness of breath.
Treatment: Amphotericin B.

Pneumocystis Pneumonia (PCP)

Etiological agent: Pneumocystis jirovecii.
Transmission: Likely person-to-person via aerosols.
Symptoms: Fever, fatigue, dyspnea, dry cough; high mortality in untreated cases.
Treatment: Trimethoprim-sulfamethoxazole.

Summary Table: Categorical Classification of SARS-CoV-2 Variants

Category	Examples of Variant’s Attributes	Examples of Public Health Actions
Variants of Interest	Predicted to affect transmission, reduce efficacy of diagnostics/therapeutics, or promote vaccine evasion; limited circulation	Enhanced surveillance, laboratory characterization, continued evaluation
Variants of Concern	Evidence of reduced efficacy of diagnostics/treatments/vaccines; increased transmissibility or severity	Notify WHO, enhanced testing, research for new vaccines/therapeutics
Variants of High Consequence	Significant reduction in efficacy of diagnostics/treatments/vaccines; clear increased transmissibility/severity	Notify WHO, announce containment strategies, recommend updates

Additional info: For all infections, supportive care, early diagnosis, and appropriate antimicrobial or antifungal therapy are critical for optimal outcomes. Vaccination remains a cornerstone for prevention of many respiratory infections.